Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2010
In vivo RNAi-mediated alpha-synuclein silencing induces nigrostriatal degenerationOleg S Gorbatyuk, Shoudong Li, Kevin Nash, et al.Frontiers in Cardiovascular Medicine|January 31, 2022
STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in DiabetesDarukeshwara Joladarashi, Yanan Zhu, Matthew Willman, et al.Frontiers in Immunology|June 9, 2020
CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of TauopathyAurelie Joly-Amado, Jordan Hunter, Zainuddin Quadri, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2010
Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic miceLori Lebson, Kevin Nash, Siddharth Kamath, et al.Neurobiology of Aging|March 14, 2013
Aging enhances classical activation but mitigates alternative activation in the central nervous systemDaniel C Lee, Claudia R Ruiz, Lori Lebson, et al.Geroscience|August 19, 2021
Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged miceAnjanet Loon, Frank Zamudio, Awa Sanneh, et al.Journal of Medicinal Chemistry|April 24, 2018
Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance MemoryAustin Horton, Kevin Nash, Ethel Tackie-Yarboi, et al.Molecular and Cellular Neurosciences|November 10, 2019
Overexpression of human wtTDP-43 causes impairment in hippocampal plasticity and behavioral deficits in CAMKII-tTa transgenic mouse modelZainuddin Quadri, Nicholas Johnson, Frank Zamudio, et al.Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritisMartin J I Andrews, J Andrew Clase, Gregory Bar, et al.Journal of Medicinal Chemistry|August 10, 2023
Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPDAndrea Rizzi, Gabriele Amari, Fausto Pivetti, et al.Pageof 5